Ocrelizumab:RA用藥
Motavizumab:RSV
Zibotentan:Prostate cancer
Atrasentan:前列腺癌、卵巢癌、腦癌
Vismodegib:胰臟癌
Fidexaban、Otamixaban、Apixaban、Betrixaban、Edoxaban、Fondaparinux:凝血因子
Vicriviroc:HIV
Taspoglutide:Type 2 diabetes
Cediranib:終止開發
Semagacestat:Alzheimer’s disease 終止開發
Dimebon:Moderate to severe Alzheimer’s disease 終止開發
pegloticase:商品名Krystexxa,痛風治療用
機轉可以參照這邊:
新機轉圖會在最近幾週出現
Carfilzomib:多發性骨髓瘤治療
Velaglucerase alfa :高雪氏症
Carglumic acid:急性高血氨
Polidocanol 靜脈硬化劑
Cabazitaxel 前列腺癌
Alcaftadine 過敏性結膜炎
Lurasidone 精神分裂症
Tesamorelin HIV lipodystrophy
Tocilizumab Rheumatoid arthritis
Collagenase clostridium histolyticum (Xiaflex) Dupuytren’s contracture
Alglucosidase alfa Pompe’s disease
IncobotulinumtoxinA (Xeomin) Cervical dystonia and blepharospasm
Hizentra Polyvalent human immunoglobulin G
Alpha1-proteinase inhibitor (Glassia) Emphysema
Sipuleucel-T (Provenge) Prostate cancer
brentuximab 淋巴瘤
Tesamorelin(Egrifta®) 愛滋病患的脂肪代謝不良
Alefacept Plaque psoriasis
Muromonab-cD3 Acute transplant rejection
Golimumab rA, PA and As
Natalizumab Multiple sclerosis
canakinumab cryopyrin-associated periodic syndrome
eculizumab Paroxysmal nocturnal haemoglobinuria
Palivizumab Prevention of rsv infection in children
rilonacept cAPs
Ustekinumab Plaque psoriasis
ruxolitinib JAK tyrosine inhibitor
Lestaurtinib JAK tyrosine inhibitor
Tasocitinib JAK3 tyrosine inhibitor
odanacatib 骨質疏鬆症
amonafide 白血症
necitumumab a next-generation version of cetuximab
iniparib poly (ADP-ribose) polymerase 1 (PARP1) inhibitor
gevokizumab interleukin‐1β (IL‐1β)‐targeted monoclonal antibody
palivizumab respiratory syncytial virus
Eribulin mesylate 晚期乳癌
Panobinostat non-selective HDAC inhibitor
selumetinib MEK inhibitor
Ambrisentan Pulmonary hypertension
Ampakines 阿茲海默症
之後會慢慢再針對這些藥物做介紹或是放進機轉圖內
留言列表